EcoDrugPlus

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSODEG00000008130
Gene Symbol: HSD11B1
3 Cross references
248 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSODEG00000015186
Gene Symbol: HCN4
3 Cross references
287 Possible Orthologues:

Hypocretin Receptor 1

Ensembl ID : ENSODEG00000003919
Gene Symbol: HCRTR1
3 Cross references
96 Possible Orthologues:

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSODEG00000006588
Gene Symbol: IDO1
3 Cross references
98 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSODEG00000013707
Gene Symbol: IMPDH1
3 Cross references
333 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSODEG00000018332
Gene Symbol: IMPDH2
2 Cross references
198 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSODEG00000008216
Gene Symbol: INPP5D
3 Cross references
213 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSODEG00000014019
Gene Symbol: IGF1R
3 Cross references
274 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSODEG00000012024
Gene Symbol: INSR
3 Cross references
288 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSODEG00000018065
Gene Symbol: ITGA2B
1 Cross references
189 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSODEG00000011915
Gene Symbol: ITGA4
3 Cross references
236 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSODEG00000014190
Gene Symbol: ITGA5
3 Cross references
269 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).